Background: Eosinophilic inflammation is a major pathologic feature of chronic rhinosinusitis (CRS) and is frequently associated with severe refractory disease. Prostaglandin (PG) D 2 levels are increased in patients with CRS, and PGD 2 is an important contributing factor to eosinophilic inflammation. Autophagy has a pleiotropic effect on immune responses and disease pathogenesis. Recent studies suggest the potential involvement of autophagy in patients with CRS and the PG pathway. Objective: We sought to investigate whether altered function of autophagy is associated with eosinophilic inflammation and dysregulated production of PGD 2 in patients with CRS. Methods: We used myeloid cell-specific deletion of autophagyrelated gene 7 (Atg7), which is vital for autophagy, and investigated the effects of impaired autophagy on eosinophilic inflammation in a murine model of eosinophilic chronic rhinosinusitis (ECRS). The effect of autophagy on PGD 2 production and gene expression profiles associated with allergy and the PG pathway were assessed.
Chronic rhinosinusitis (CRS) is a common upper airway disease characterized by chronic inflammation of the sinonasal mucosa with significant health effects. [1] [2] [3] [4] CRS is a multifactorial inflammatory disorder with heterogeneous clinical features, histopathology, and efficacy of medications. [5] [6] [7] Such a heterogeneous nature of the disease confounds the identification of etiologic factors in patients with CRS. Defects in the innate immune system were recently proposed as important contributors to the initiation and amplification of inflammation in patients with CRS. [2] [3] [4] [5] Inflamed tissues from patients with CRS display a different spectrum of inflammatory mediators and infiltrated innate effector cells, including eosinophils, neutrophils, mast cells, and macrophages. Primary interest has centered on regulation of eosinophils in patients with CRS because eosinophilic inflammation is dominant in patients with severe refractory CRS. 6, 7 Thus there is growing attention to understanding the mechanisms that promote and perpetuate eosinophilic inflammation in patients with CRS.
Production of prostaglandin (PG), especially PGD 2 , is dysregulated in patients with eosinophilic chronic rhinosinusitis (ECRS) and considered an important contributing factor to eosinophilic inflammation. Expression of prostaglandin D 2 synthase (PGDS) is increased in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and positively correlates with eosinophilic inflammation. 8 Upregulation of PGD 2 in nasal polyps (NPs) strongly correlates with the number of mast cells that produce mainly PGD 2 and that play an important role in orchestrating eosinophil infiltration in patients with CRS. [9] [10] [11] Furthermore, PGDS overexpression that leads to overproduction of PGD 2 promotes pronounced lung infiltration of eosinophils, but not neutrophils, in a murine asthma model. 12 Despite its significance in ECRS pathogenesis, the mechanisms by which PGD 2 dysregulation occurs in patients with CRS remain unclear.
Autophagy is an evolutionarily conserved intracellular process through which compromised organelles and invading pathogens are sequestered and cleared. 13 It also plays a pivotal role in shaping cellular immune responses and progression of diverse inflammatory diseases. [14] [15] [16] Studies on genetic polymorphisms involving autophagy-related gene 5 (Atg5) and increased expression of Atg5 in the nasal mucosa revealed a causal association of autophagy with asthma pathogenesis. 17, 18 Moreover, autophagy deficiency in CD11c 1 cells promotes neutrophilic airway inflammation in a murine asthma model, 19 supporting a direct contribution of autophagy to neutrophilic lung inflammation. Despite significant progress made regarding the role of autophagy as a pivotal contributor to inflammatory diseases, including asthma, few studies have been conducted on the association of autophagy with CRS pathogenesis. Recent reports provide some clues concerning the potential role of autophagy in patients with CRS by demonstrating autophagy deficiency in NPs and its inverse correlation with COX-2 expression. 20, 21 However, no study has sought to assess the direct role of autophagy in the development of CRS, especially ECRS. In the present study we obtained evidence indicating that autophagy deficiency in myeloid cells, particularly macrophages, is linked to PGD 2 dysregulation and eosinophilic inflammation in a murine model of ECRS.
METHODS Animals
To generate Atg7 f/f ;Lyz2-Cre mice with myeloid cell-specific deletion of Atg7, we crossed Lyz2-Cre mice (stock number 4781; Jackson Laboratories, Bar Harbor, Me) with Atg7 f/f mice (kindly provided by Masaaki Komatsu of Niigata University, Niigata, Japan). Littermates were used in all experiments. The genotypes of the mice were analyzed with PCR by using established primers. 22 All experimental protocols were approved by the Institutional Animal Care and Use Committee of the Asan Institute for Life Science.
Murine CRS model
ECRS was induced by means of intranasal challenge with a mixture of Aspergillus oryzae protease (Sigma-Aldrich, St Louis, Mo) and ovalbumin (Worthington Biochemical, Lakewood, NJ), as described with minor modifications. 23 To deplete macrophages, mice were given an intranasal injection of clodronate liposome (ClodronateLiposomes.com, Amsterdam, the Netherlands). After CRS development, blood samples were collected, and nasal tissue sections were obtained and stained, as previously described. 23 Mast cell infiltration was detected by using acidic toluidine blue staining, as previously reported. 24 Quantitative real-time RT-PCR and RT 2 
Profiler PCR Arrays
The mouse Allergy and Asthma RT 2 Profiler PCR Array (Qiagen/SA Biosciences, Frederick, Md) was used to study the effects of impaired autophagy on gene expression profiles related to eosinophilic inflammation in the setting of CRS, according to the manufacturer's recommendations. mRNA levels of hematopoietic prostaglandin D 2 synthase (H-PGDS), microsomal prostaglandin E synthase 1 (mPGES1), and COX-2 were determined by using quantitative real-time RT-PCR (qRT-PCR).
Immunofluorescence and immunohistochemistry
Tissue sections were immunostained for LC3B in combination with markers for macrophages (F4/80 and CD68), neutrophils (Ly6G), or eosinophils (Sirius red) to detect types of myeloid cells linked to autophagy deficiency. Association of H-PGDS levels with tissue eosinophilia was examined after staining of tissue sections with Sirius red, followed by anti-H-PGDS antibody. system equipped with a 1290 HPLC (Agilent Technologies, Santa Clara, Calif), Qtrap 5500 (AB Sciex, Framingham, Mass), and a reverse-phase column (Pursuit 5, 200 3 2.0 mm) was used for PGD 2 analysis. PGD 2 was quantified with PGD 2 -d 4 as the internal standard.
Statistical analysis
All data were analyzed with GraphPad Prism software (version 4.00; GraphPad Software, La Jolla, Calif). Groups were compared by using nonparametric Mann-Whitney U tests. Statistical significance was defined as a P value of less than .05.
RESULTS

Aggravation of ECRS by autophagy deficiency in myeloid cells
A previous study indicates an important contribution of autophagy in immune cells, specifically CD11c
1 cells, to the induction of neutrophilic lung inflammation. 19 However, its contribution to eosinophilic airway inflammation remains undefined. In this respect we studied the role of autophagy in the development of ECRS using mice with myeloid cell-specific deletion of Atg7 (hereafter denoted as Atg7 f/f ;Lyz2-Cre mice). In these mice the key autophagy gene Atg7 is deleted in cells of myeloid origin, such as macrophages, neutrophils, and eosinophils, that infiltrate the sinonasal mucosa during CRS pathogenesis. [2] [3] [4] [5] Atg7
;Lyz2-Cre mice exhibited no developmental abnormalities and had normal reproductive ability. Moreover, these mice displayed normal histology in the sinonasal tissues without noticeable infiltration of inflammatory cells (data not shown), even when evaluated in aged mice (10 months). Thus autophagy deficiency in myeloid cells appears not to disrupt the maintenance of normal sinonasal homeostasis.
Next, we investigated the effect of autophagy deficiency on eosinophilic inflammation by using a previously established murine model of ECRS. One day after the last challenge, the severity of blood and tissue eosinophilia was examined. Among leukocytes examined, we identified that the number of blood eosinophils was significantly increased and was greater in Atg7 f/f ;Lyz2-Cre CRS mice than in Atg7 f/f CRS mice (P < .001; Fig 1, A) . Histologic analyses revealed that epithelial hyperplasia and maximal mucosal thickness were more pronounced in Atg7 f/f ;Lyz2-Cre mice with CRS than in Atg7 f/f mice with CRS (P < .05; Fig 1, B and C) . In addition, the number of eosinophils infiltrating the sinonasal mucosa was significantly greater in Atg7 f/f ;Lyz2-Cre mice with CRS than in Atg7 f/f mice with CRS (P < .05; Fig 1, B and C) . Collectively, these results indicated a protective effect of myeloid cell autophagy on blood and tissue eosinophilia in a murine model of CRS.
Autophagy deficiency affects gene expression profiles related to eosinophilic inflammation and the PGD 2 pathway
To gain insight into underlying mechanisms, we next assessed gene expression in the sinonasal tissue of mice with CRS. To this end, we used a PCR array to monitor the expression of a selected set of 84 genes central to allergy and asthma. Differentially expressed genes were identified as those that were either upregulated or downregulated by more than 3-fold in Atg7 f/f ;Lyz2-Cre mice with CRS compared with Atg7 f/f mice with CRS. Our analyses revealed that autophagy deficiency caused substantial changes in gene expression profiles of sinonasal tissue from mice with CRS (Fig 2, A and B , and see Table  E1 in this article's Online Repository at www.jacionline.org). Such an abundance of genes showing differential expression suggests a crucial role of autophagy in the regulation of allergic responses. Importantly, genes associated with eosinophils (eg, Rnase2a, Rnase2b, and Itga4) were upregulated markedly by autophagy deficiency, correlating with the increase in eosinophilic inflammation. A notable increase was also observed for genes related to eosinophil survival and activation (Il3, Il5, Il13, Il3ra, Il5ra, and Il13ra2), as well as recruitment (Ccl5, Ccl11, Ccl24, and Ccl26).
In support of this, substantial increases in mRNA expression were observed for genes encoding thymic stromal lymphopoietin (TSLP) and IL-1 receptor-like 1 (IL1RL1), which are linked to T H 2 response and eosinophilia. [25] [26] [27] Furthermore, there was an apparent increase in gene expression (Arg1, Chil1, and Mrc1) associated with alternatively activated (M2) macrophages that promote eosinophil recruitment. 28 Among others, genes (Ptgdr2 and Pparg) that encode the receptor for PGD 2 and its metabolites were notably upregulated. These results raise the possibility that autophagy deficiency can provoke eosinophilic inflammation involving dysregulation of the PGD 2 pathway.
Autophagy deficiency is linked to PGD 2 dysregulation
Next, we evaluated whether the lack of autophagy could affect mRNA levels of PGDS, prostaglandin E 2 synthase (PGES), and COX-2, which are required for PG production and also implicated in CRS pathophysiology. 8 Relative mRNA levels of H-PGDS, mPGES-1, and COX-2 in the sinonasal tissue of mice with CRS were determined by using qRT-PCR and normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh) mRNA. We found a significant increase in mRNA levels of H-PGDS and COX-2 but significantly diminished mRNA levels of mPGES-1 by autophagy deficiency (P < .05; Fig 2, C) . This result is consistent with a prior report showing an inverse correlation between PGDS and PGES expression and its correlation with tissue eosinophilia in the setting of CRS. 8, 29 The activation of peroxisome proliferatoractivated receptor g (Pparg), expression of which was notably increased by autophagy deficiency (Fig 2, A and B) , promotes macrophage M2 polarization and mPGES-1 downregulation. [30] [31] [32] In support, we found a reciprocal regulation of H-PGDS and mPGES-1 expression in activated macrophages exposed to an agonist of Pparg (rosiglitazone, see Fig E1 in this article's Online Repository at www.jacionline.org). Moreover, immunohistochemical staining confirmed a significant increase in H-PGDS protein levels that was concomitant with tissue eosinophilia by autophagy deficiency (P < .001; Fig 2, D) .
Mast cells mainly produce PGD 2 and play crucial pathogenic roles in the setting of ECRS. We counted the infiltration of mast cells into the sinonasal tissue of mice with CRS, which was visualized by using acidic toluidine blue staining. The number of infiltrated mast cells was increased in Atg7 f/f ;Lyz2-Cre mice with CRS compared with that in Atg7 f/f mice with CRS (P < .01; Fig 2, E) . Supporting this, genes associated with mast cells (Cma1, Cpa3, Fcer1a, and Ms4a2) were clearly upregulated by autophagy deficiency (Fig 2, A and B) .
To probe the role of autophagy in the regulation of PGD 2 production, we used an established model of acute peritoneal inflammation induced by zymosan treatment. 33, 34 In this model PGD 2 derived from mast cells and macrophages contributes to the resolution of peritonitis, which enabled the assessment of PGD 2 production by autophagy deficiency despite the differences in pathophysiology. Levels of PGD 2 in peritoneal exudates was determined by using LC-MS/MS. Atg7 f/f ;Lyz2-Cre mice had significantly higher levels of PGD 2 than Atg7 f/f mice (P < .05, see Fig ;Lyz2-Cre and control Atg7 f/f mouse groups by means of a heat map (upper) and gene tables (lower). B, Representative scatter plot. Fold changes of greater than 3 were considered to represent significant gene dysregulation through either upregulation (red) or downregulation (green). C, Relative mRNA levels corresponding to the indicated proteins were determined by using qRT-PCR and normalized to Gapdh mRNA. D, Representative immunostaining for H-PGDS and Sirius red counterstaining in the sinonasal tissue from each group of mice. The statistical bar chart shows the H-PGDS-positive area. Scale bars 5 50 mm. E, Representative photographs of acidic toluidine blue-stained sections and quantitative analysis of mast cell infiltration. The statistical bar chart shows the area of toluidine blue-positive mast cells. Scale bars 5 50 mm. Data are expressed as means 6 SEMs. *P < .05, **P < .01, ***P < .001, #P < .05, and ##P < .01, Mann-Whitney U test.
www.jacionline.org). Collectively, our results suggest an association of autophagy deficiency with eosinophilic inflammation through an effect on PGD 2 dysregulation. PGD 2 promotes eosinophil recruitment by acting through chemoattractant receptor-like molecule on T H 2 cells (DP2). 35 Eosinophilia in peripheral blood and sinonasal tissue caused by autophagy deficiency was significantly alleviated by an antagonist of DP2 (TM30089; see Fig E3 , A and B, in this article's Online Repository at www.jacionline.org). Furthermore, epithelial hyperplasia and maximal mucosal thickness were significantly decreased in Atg7 f/f ;Lyz2-Cre mice with CRS (see Fig E3, B and C), an observation compatible with TM30089-mediated inhibition of peribronchial eosinophilia and mucus cell hyperplasia. 36 These results suggest that PGD 2 dysregulation associated with impaired autophagy might be an important contributing factor in aggravating eosinophilic inflammation in the setting of CRS.
Macrophages undergo autophagy in the sinonasal mucosa of mice with CRS
To investigate types of myeloid cells that undergo autophagy during CRS, we examined localization of LC3B, a widely used marker for autophagy, in association with markers for different types of myeloid cells. Immunohistochemical analysis revealed a marked increase in LC3B staining, including detectable LC3B puncta in the sinonasal tissue of mice with CRS compared with that of control mice. Of note, such LC3B staining was often colocalized with F4/80 1 and CD68 1 macrophages that infiltrated the sinonasal mucosa of Atg7 f/f CRS mice, which was hardly observed in Atg7 f/f ;Lyz2-Cre mice with CRS lacking autophagy in myeloid cells (Fig 3) . These data reinforce the specificity of our immunohistochemical analysis and the role of macrophage autophagy in ECRS. In comparison, we observed less colocalization of LC3B staining with Ly6G 1 neutrophils and Sirius red-positive eosinophils 
Autophagy-deficient macrophages aggravate ECRS
To probe the pathogenic role of autophagy-deficient macrophages in the eosinophilic inflammation of CRS, we assessed the severity of blood and tissue eosinophilia by macrophage depletion with clodronate liposome treatment. 37 Efficacy of clodronate liposome-mediated depletion was confirmed in sinonasal mucosa stained for the presence of F4/80 1 macrophages (see Fig E5 in this article's Online Repository at www.jacionline.org). We found that blood eosinophils in Atg7 f/f ;Lyz2-Cre mice with CRS were significantly decreased by macrophage depletion with clodronate liposome (P < .05; Fig 4, A) , whereas blood eosinophils in Atg7 f/f mice with CRS remained unchanged by the same treatment. Histologic analyses revealed that clodronate liposome treatment also significantly decreased epithelial hyperplasia, maximal mucosal thickness, and numbers of eosinophils, but not Ly6G 1 neutrophils, infiltrating the sinonasal mucosa of Atg7 (Fig 4, B and C). Mice with CRS treated with control PBS-encapsulated liposomes had ECRS, similar to that noted in untreated CRS mice (Fig 4 and data not shown) .
Having observed the contribution of autophagy deficiency to PGD 2 dysregulation, we next examined whether such depletion of autophagy-deficient macrophages could affect the expression of H-PGDS that is linked to eosinophilic inflammation of CRS. 8 We found that clodronate liposome treatment significantly reduced H-PGDS levels in the sinonasal mucosa of Atg7 f/f ;Lyz2-Cre mice with CRS (P < .05; Fig 5, A) . This decrease correlated with the reduced number of infiltrated mast cells in Atg7 f/f ;Lyz2-Cre mice with CRS (P < .05; Fig 5, B) . Collectively, our results suggested a protective role of macrophage autophagy in the eosinophilic inflammation seen in patients with CRS through effects on PGD 2 regulation.
ECRS by autophagy deficiency is IL-1 dependent
Finally, we investigated the possible mechanism by which autophagy-deficient macrophages aggravate the eosinophilic inflammation seen in CRS. We focused on inflammatory mediators derived from macrophages and noticed a clear upregulation of Il18 mRNA in sinonasal tissue of Atg7 f/f ;Lyz2-Cre mice with CRS (Fig 2, A and B) . A significant increase in mRNA levels of IL-1b and IL-6 but not IL-1a and TNF-a, as determined by using qRT-PCR, were also observed (see Fig E7 in IL-1b is the cytokine produced primarily by macrophages and monocytes and significantly potentiates the production of PGD 2 and type 2 cytokines by mast cells under inflammatory conditions. 39, 40 Thus we tested the involvement of IL-1 in the aggravation of eosinophilic inflammation and PGD 2 dysregulation by autophagy deficiency. Mice were administered IL-1 receptor blocking antibody during the development of ECRS. Blockade of IL-1 receptor significantly alleviated eosinophilia in blood and sinonasal mucosa of Atg7 f/f ;Lyz2-Cre mice with CRS compared with Atg7 f/f mice with CRS (Fig 6, A and B) . Epithelial hyperplasia and maximal mucosal thickness were also significantly decreased by IL-1 blockade in Atg7 f/f ;Lyz2-Cre mice with CRS (P < .01; Fig 6, B and C) . Furthermore, the same treatment significantly reduced levels of H-PGDS and numbers of mast cells in the sinonasal mucosa of Atg7 f/f ; Lyz2-Cre mice with CRS (Fig 6, D and E) . Collectively, these results suggest IL-1, including IL-1b, as a potential candidate mediator implicated in PGD 2 dysregulation and eosinophilic inflammation by autophagy deficiency, although we cannot exclude the possible contribution of other mediators.
DISCUSSION
Autophagy has been implicated in the regulation of diverse inflammatory diseases, including severe asthma, whereas its role in the setting of CRS, especially with respect to eosinophilic inflammation, is yet to be explored. Recent studies revealed that levels of the autophagosome marker LC3 decreased in NPs of patients with CRS and that it correlates inversely with COX-2 expression, 20, 21 suggesting a potential role of autophagy in CRS pathogenesis. For the first time, our study findings demonstrate that autophagy deficiency in myeloid effector cells, particularly macrophages, aggravates eosinophilic sinonasal inflammation and blood eosinophilia in a murine model of CRS. Importantly, we showed that loss of autophagy is associated with augmented production of PGD 2 , which is concomitant with the upregulation of multiple components in the PGD 2 pathway. This dysregulation of the PGD 2 pathway correlated with increased infiltration of mast cells and promoted aggravation of eosinophilic inflammation. Moreover, the findings of alleviation of eosinophilic inflammation and PGD 2 dysregulation through depletion of autophagy-deficient macrophages exhibiting high levels of IL-1b suggests that macrophage autophagy has an important role in regulating eosinophilic inflammation and ECRS development.
Eosinophilic inflammation is considered a major pathologic hallmark of CRS 7, 41 and is frequently associated with refractory CRS and recurrence of NPs after medical and surgical intervention. 42 In patients with ECRS, peripheral blood eosinophilia correlates well with eosinophilic inflammation in the sinonasal mucosa. 42, 43 Considering its intractable features, eosinophilic inflammation is a major therapeutic target in patients with CRS, 44 as well as those with asthma. 45 To probe the role of autophagy in eosinophilic inflammation, we used a previously established ECRS mouse model induced by a combination of Aspergillus species protease and ovalbumin. 23, 46 This model exhibits blood eosinophilia and chronic eosinophilic sinonasal inflammation, including T H 2 polarization and epithelial hyperplasia. In our current study impaired autophagy in myeloid cells of mice with ECRS led to induction of blood eosinophilia and aggravation of eosinophilic sinonasal inflammation and tissue hyperplasia. In support, genes closely related to eosinophils (Rnase2a, Rnase2b, and Itga4) and T H 2 polarization (Tslp and Il1rl1) were markedly upregulated by the impaired autophagy. Moreover, a large increase was observed for genes encoding multiple cytokines (Il3, Il5, and Il13) and their receptors (Il3ra, Il5ra, and Il13ra2) that promote eosinophil survival and activation, as well as chemokines (Ccl5, Ccl11, Ccl24, and Ccl26) involved in the recruitment of CCR3-expressing eosinophils. Collectively, these results imply that impaired autophagy in myeloid cells can provoke pathologic changes in gene expression, which promote chronic eosinophilic inflammation in a murine model of ECRS.
Another important finding in our study is the role of autophagy in mediating effects on PGD 2 regulation. PGD 2 , one of the major mast cell-produced PGs, is important in type 2 inflammation, primarily through recruitment of T H 2 cells, eosinophils, and basophils 35 and production of type 2 cytokines. 47 In addition, PGD 2 can promote eosinophilic inflammation through suppression of natural killer cell function and natural killer cell-mediated eosinophil apoptosis. 23 In a murine model of allergic asthma, PGD 2 and PGDS were responsible for triggering pronounced eosinophilic inflammation and T H 2 cytokine release. 12 Furthermore, direct application of PGD 2 induces eosinophilic airway inflammation. 48 In patients with CRSwNP, levels of mRNA encoding H-PGDS were significantly increased and correlated with the degree of eosinophil infiltration and disease severity. 8 In comparison, levels of mRNA encoding PGES and PGE 2 concentrations were downregulated. 8, 49 Of interest, impaired autophagy in myeloid cells of mice with ECRS could recapitulate the results of such an inverse correlation between H-PGDS and PGES levels and their correlation with the tissue eosinophilia seen in patients with CRSwNP. The association of autophagy with PGD 2 regulation is also supported by our findings that impaired autophagy provoked notable upregulation of genes (Ptgdr2 and Pparg) encoding receptors for PGD 2 and its metabolite in addition to a significant increase in PGD 2 production. Moreover, autophagy deficiency was associated with an increased number of mast cells in the sinonasal mucosa of CRS mice. In this respect autophagy can coordinate levels of PGD 2 production and components related to the PGD 2 pathway, the underlying mechanism of which requires further study. Given a significant alleviation of eosinophilia by an antagonist of DP2, our results collectively suggest PGD 2 dysregulation by autophagy deficiency as a potential mechanism that drives eosinophilic inflammation in patients with CRS.
Our results also suggest that autophagy in macrophages among myeloid effector cells has a protective role against the development of ECRS. We identified that depletion of autophagy-deficient macrophages in mice with ECRS results in significant alleviation of blood and sinonasal eosinophilia, along with a reduction in H-PGDS levels and mast cell numbers in the inflamed sinonasal mucosa. Supporting this, blockade of IL-1, including IL-1b, which was upregulated in autophagy-deficient macrophages, similarly reduced H-PGDS levels, mast cell numbers, and eosinophilic inflammation associated with autophagy deficiency. Macrophages are major producers of inflammatory cytokines and chemokines and are known to be accumulated in significantly increased numbers in the nasal mucosa of patients with CRSwNP. 50, 51 Compared with eosinophils and mast cells, the role of macrophages in the pathogenesis of ECRS is still unclear. Alteration in macrophage phenotype can occur in the presence of the T H 2 cytokines IL-4 and IL-13, which are abundant in the sinonasal mucosa of patients with ECRS. 7 These M2 macrophages were reported to be increased in NP tissue and positively correlated with IL-5 levels in the nasal mucosa, 51 implicating their roles in ECRS pathogenesis. M2 macrophages can contribute to the recruitment of polarized T H 2 cells and eosinophils 28 and have thus been linked to the persistence of allergic disease and asthma. 52 Recent studies suggest a potential link between M2 macrophages and eosinophilia in the setting of CRSwNP, 4, 53 in which eosinophil production of CCL23 recruiting macrophages and macrophage release of eotaxins (eg, CCL11 and CCL26) that recruit eosinophils form a positive feedback loop to amplify eosinophilia. Of interest, the loss of autophagy in myeloid cells led to an increase in the expression of genes encoding the T H 2 cytokines IL-4 and IL-13, which can suppress autophagy in macrophages. 54 Hence we speculate that impaired autophagy in macrophages, as demonstrated here, can occur during the course of ECRS, which in turn aggravates and perpetuates eosinophilic inflammation, possibly through an IL-1-dependent mechanism. In this respect further study will be required to address the exact underlying mechanisms involved.
Of interest is the finding that, in addition to macrophages, other types of myeloid cells, particularly eosinophils, also underwent autophagy in the sinonasal mucosa during ECRS, although not as clear as macrophages. Using cotreatment with LPS and rapamycin as a positive control (see Fig E9, A and B, in this article's Online Repository at www.jacionline.org), we found that a small fraction of eosinophils in the blood of Atg7 f/f CRS mice also showed increased LC3B expression, which was not apparent in autophagy-deficient Atg7 f/f ;Lyz2-Cre mice with CRS (see Fig E9, C and D) . Autophagy was reported to be increased in sputum and blood eosinophils from patients with severe asthma. 55 Thus alteration in eosinophil autophagy might contribute to ECRS pathogenesis, given its role in counterregulation of eosinophil cytolysis, 56 which is linked to the severity of asthma exacerbation. 57 In support of this notion, there were still significant differences in eosinophil numbers and mucosal thickness between Atg7 f/f mice with CRS and Atg7 f/f ;Lyz2-Cre mice with CRS, even after macrophage depletion (P < .01; Fig 4, B) , suggesting the possible contribution of autophagy deficiency in myeloid cells other than macrophages, including eosinophils, to ECRS. In this respect further study will be required to dissect the role of autophagy in other types of myeloid cells in patients with ECRS.
Emerging evidence suggests that autophagy functions as an important regulator of immune responses and has multiple effects on inflammation, either proinflammatory or anti-inflammatory. [14] [15] [16] Lack of autophagy in CD11c 1 cells, especially dendritic cells, results in severe IL-17-mediated neutrophilic lung inflammation, suggesting the protective role of autophagy in neutrophilic asthma. 19 In our present study loss of autophagy in myeloid cells, particularly macrophages, exacerbated eosinophilic inflammation involving PGD 2 dysregulation, which suggests the protective role of autophagy in patients with ECRS. In contrast, autophagy deficiency in the same myeloid cells reduced neutrophil degranulation and the severity of neutrophil-mediated inflammatory and autoimmune diseases. 58 These studies indicate that inflammation affected by autophagy appears to be diverse and context dependent, according to the types of immune cells and disease models, thus supporting a diverse role of autophagy in immune cell functions. In addition to its role in inflammation, autophagy can affect T H cell polarization, partly through control of innate immune cells.
14 Autophagy-deficient myeloid cells, especially macrophages, significantly enhanced levels of the T H 1 cytokine IFN-g during dextran sulfate sodium-induced colitis 59 and GalN/LPS-induced liver injury. 60 Impaired autophagy in myeloid cells also promoted T H 17 responses during Mycobacterium tuberculosis infection. 61 In this respect our results of T H 2 cytokine regulation by myeloid autophagy in the context of ECRS suggest a broad effect of autophagy on diverse T H responses according to the context and disease model involved.
In summary, we demonstrate here a previously unappreciated aspect of the protective effect of autophagy on the pathophysiology of CRS in the context of PGD 2 dysregulation and eosinophilic inflammation. Our results reveal that impaired autophagy provokes eosinophilic and type 2 inflammation in a murine model of ECRS and that this pathologic change largely relies on altered macrophage function. In support of autophagy as a versatile immune modulator, our results suggest further that autophagy plays a significant role in T H 2-biased eosinophilic inflammation in CRS pathogenesis. Our findings also imply that enhancing the autophagy pathway might be an effective therapeutic strategy for the resolution of eosinophilic inflammation in patients with CRS.
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Key messages
d Autophagy deficiency in myeloid cells aggravates eosinophilic inflammation in a murine model of ECRS.
d Impaired autophagy was associated with dysregulation of IL-1 and the PGD 2 pathway and increased infiltration of mast cells.
d Depletion of autophagy-deficient macrophages led to alleviation of eosinophilic inflammation and PGD 2 dysregulation.
METHODS Animal
To generate Atg7 f/f ;Lyz2-Cre mice with myeloid cell-specific deletion of Atg7, a key autophagy gene, we crossed Lyz2-Cre mice (stock no. 4781; Jackson Laboratories) with Atg7 f/f mice (kindly provided by Masaaki Komatsu of Niigata University). Littermates were used in all experiments. PCR genotyping was conducted with the following primers: 59-CCC AGA AAT GCC AGA TTA CG-39 for wild-type, 59-CTT GGG CTG CCA GAA TTT CTC-39 for both genotypes, and 59-TTA CAG TCG GCC AGG CTG AC-39 for Cre in Lyz2-Cre mice, and 59-CCA CTG GCC CAT CAG TGA GCA TG-39 for wild-type, 59-CAT CTT GTA GCA CCT GCT GAC CTG C-39 for common, and 59-GCG GAT CCT CGT ATA ATG TAT GCT ATA CGA AGT TAT-39 for loxP in Atg7 f/f mice. Animals were bred at the Laboratory Animal Facility of the Asan Institute for Life Sciences under specific pathogen-free conditions and maintained at a constant ambient temperature (228C 6 18C) with a 12-hour/12-hour light/dark cycle. Animals were housed 3 to 5 per cage with ad libitum access to food and water. All experimental protocols were approved by the Institutional Animal Care and Use Committee of the Asan Institute for Life Science.
Murine CRS model
ECRS was induced by means of intranasal challenge with a mixture of 1 U of protease from A oryzae (Sigma-Aldrich) and OVA (Worthington Biochemicals) diluted in sterile PBS to a total volume of 20 mL 3 times a week for 5 weeks, as previously described, with slight modifications.
E1
Control mice were intranasally challenged with PBS. To deplete macrophages, mice were administered an intranasal injection of 40 mL of clodronate liposomes (ClodronateLiposomes.com). Control mice were injected with control liposomes (ClodronateLiposomes.com). The first injections of clodronate or control liposomes were performed 1 day before intranasal challenge with protease combined with ovalbumin and then 2 times a week for 5 weeks until death. Mice were injected with anti-IL-1 receptor antibody administered intranasally (50 mg per mouse, JAMA-147; Bio X cell, West Lebanon, NH) and intraperitoneally (300 mg per mouse, JAMA-147) on alternate days in a total of 6 times a week for 5 weeks to block IL-1 receptor. Control mice were injected equally with Armenian hamster IgG (Bio X cell) on the same days. The first intranasal injections of anti-IL-1 receptor antibody or control IgG were performed 2 hours before intranasal challenge with protease combined with OVA. Mice were given an intranasal injection of 24 mL of TM30089 (1 mg/kg; Cayman Chemicals) to block the DP2 receptor. Control mice received vehicle (PBS containing 12% dimethyl sulfoxide). The first injections of TM30089 or vehicle were performed 1 hour before intranasal challenge with protease combined with OVA and then 6 times a week for 5 weeks until death.
Eosinophil cell counts in blood
Blood samples were taken by means of cardiac puncture, and differential cell counting was performed with the ADVIA 2120 Hematology System (Bayer HealthCare, Diagnostics Division, Tarrytown, NY).
Histologic analysis
Nasal tissue sections were stained with hematoxylin and eosin or Sirius red and analyzed by a pathologist from the Department of Pathology, Asan Medical Center, who was blind to the group assignments. Epithelial hyperplasia was scored on a scale of none (0), minimal (1), mild (2), moderate (3), and severe (4). Minimal was defined as barely detectable, mild as slightly detectable, moderate as easily detectable, and severe as very evident. The maximal mucosal thickness was measured at the transition zone of the olfactory and respiratory epithelia by using an image analysis system (CellSens Standard 1.7). Infiltration of eosinophils in the lamina propria was expressed as the number of cells per high-powered field. Slides of consecutive sections were dewaxed, rehydrated, and stained with acidified (0.02% in 0.25% glacial acetic acid) toluidine blue to detect mast cells in sinonasal tissues of mice with CRS.
E2
Detection of LC3B expression in eosinophils
Leukocytes were isolated from peripheral blood by means of centrifugation and lysis of red blood cells. Thereafter, cells (1 3 10 6 cells) were incubated with Fcg receptor-binding inhibitor (eBioscience, San Diego, Calif) for 20 minutes at 48C and stained for surface markers with anti-Siglec-F-phycoerythrin and anti-CCR3-fluorescein isothiocyanate antibodies for 1 hour in the dark at 48C. E3 
Immunofluorescence and confocal analysis
To detect macrophages or neutrophils in the sinonasal tissues of mice with CRS, slides were incubated with primary antibodies against F4/80 (1:100, CI:A3-1; AbD Serotec, Oxford, United Kingdom), CD68 (1:100, FA-11; AbD Serotec), Ly6G (1:100, 1A8; BD Biosciences), IL-1b (1:100, 3A6; Cell Signaling, Danvers, Mass), and against LC3B (1:250; Novus Biologicals) for 1 hour, followed by Alexa Fluor 488-conjugated goat anti-rat F(ab9)2 (1:250; Jackson ImmunoResearch) or Alexa Fluor 488-conjugated goat anti-mouse F(ab9)2 (1:250; Jackson ImmunoResearch) and Alexa Fluor 647-conjugated goat anti-rabbit F(ab9)2 (1:250; Jackson ImmunoResearch) for 30 minutes in PBS containing 1% BSA and 1% goat serum. All incubations were performed under coverslips at room temperature, followed by 3 washes with PBS. Coverslips were mounted with ProLong Gold anti-fade reagent (Molecular Probes, Eugene, Ore). Cells were imaged with an LSM 710 laser-scanning confocal microscope (Carl Zeiss, Oberkochen, Germany). Colocalization of LC3B with eosinophils was also detected by using a fluorescent property of Sirius red. LC3B expression was localized by means of immunofluorescence staining with Alexa Fluor 647-conjugated goat anti-rabbit F(ab9)2 (1:250; Jackson ImmunoResearch). The excitation and emission wavelengths were 543 and 633 nm for Sirius red staining and 633 and 647 nm for LC3B staining, as previously described.
E4
Immunohistochemistry
To detect LC3B on eosinophil counts or H-PGDS levels in the sinonasal tissues of mice with CRS, slides were first stained with Sirius red to identify eosinophils and incubated with primary antibodies against LC3B (1:200; Novus Biologicals) or H-PGDS (1:100; Cayman Chemicals) for 1 hour, respectively, and stained with Vectastatin ABC kits (peroxidase, rabbit IgG; Vector Laboratories, Burlingame, Calif) according to the manufacturer's instructions. The diaminobenzidine (DAB) signal was observed by using the DAB substrate kit (Roche Diagnostics, Mannheim, Germany).
Image quantification
Slides after immunohistochemical staining were scanned with the Vectra slide scanner (PerkinElmer, Waltham, Mass) to identify DAB staining, and the spectral library of hematoxylin or Sirius red was created. Then inForm image analysis software (PerkinElmer) was applied to quantify the spectra in the sinonasal tissues. Fluorescence was analyzed with ImageJ software (National Institutes of Health, Bethesda, Md) in digital fluorescence microscopic images in a total of 6 randomly chosen fields (420 3 420 mm). Based on analysis of pixel fluorescence intensities, which ranged from 0 to 255, the signal for F4/80, CD68, Ly6G, IL-1b, or LC3B was distinguished from background by empirically counting only those pixels above a threshold value, thus maximizing the inclusion of only those pixels with specific antigen staining. The area density was calculated as the percentage of total pixels with a fluorescence intensity value equal to or greater than the threshold.
qRT-PCR and RT 2 Profiler PCR Arrays
The skull was bisected from the snout and septal and turbinate mucosae were removed and placed immediately in RNAlater solution (Invitrogen) to harvest nasal tissue for RNA extraction. All harvested sinonasal tissues were included in RNA extraction. RNA was isolated from nasal tissue by using the RNeasy Microarray Tissue Mini Kit (Qiagen). qRT-PCR was used to quantify the amounts of mRNA in the nasal tissue by using mouse Allergy and Asthma RT 2 Profiler PCR Arrays (Qiagen/SA Biosciences). cDNA was synthesized from 2 mg of total RNA by using SuperScript III reverse transcriptase (Invitrogen). Thereafter, RT-PCR was performed with the SuperArray Master Mix (Qiagen) and a Roche LightCycler 480 instrument, according to the manufacturer's instructions. Experiments were performed on RNA pooled from 4 to 5 individual mice per group of mice. cDNA was synthesized from 1 mg of total Data are expressed as means 6 SEMs. *P < .05, **P < .01, ***P < .001, #P < .05, and ##P < .01, Mann-Whitney U test. 
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